HELM INTELLIGENCETMO
Preparing your analysis.
We’re bringing the available data and research into view. Your report will appear here when it’s ready.
Working on your request
We’re bringing the available data and research into view. Your report will appear here when it’s ready.
Investors should consider the current fundamentals and growth projections when evaluating Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. has a market capitalization of $245.13B and a current stock price of $648.49, up 1.06% from the previous close of $641.66. The company exhibits a P/E ratio of 36.56 and a dividend yield of 0.26%. Revenue growth year-over-year stands at 3.91%, while EPS growth is reported at 7.32%. The company’s return on equity is 12.55%, and its current ratio is 1.89.
Some investors point to Thermo Fisher's projected 7% organic growth by 2028, driven by increased pharmaceutical spending influenced by AI developments. Additionally, the company anticipates stronger demand, labeling 2026 as an 'Outstanding Year'.
Conversely, concerns arise from the modest revenue growth of 3.91% year-over-year, which may indicate potential challenges in maintaining momentum. The relatively high P/E ratio of 36.56 could also suggest that the stock is priced for perfection, raising risk levels for investors.
Hold TMO? See what it does to your whole book.
Connect a brokerage read-only and Helm shows TMO next to everything you hold: how concentrated you are, what moved today, and a daily brief on all of it. Free, no card.
See TMO in my portfolioHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Watch my tickers
Get an email when something changes on your tickers: the exact quote, dated and sourced. No account, no brokerage connection, unsubscribe anytime.
Hold TMO? See what it does to your whole book.
Connect a brokerage read-only and Helm shows TMO next to everything you hold: how concentrated you are, what moved today, and a daily brief on all of it. Free, no card.
See TMO in my portfolioThermo Fisher Scientific Inc. has a market capitalization of $245.13B and a current stock price of $648.49, up 1.06% from the previous close of $641.66. The company exhibits a P/E ratio of 36.56 and a dividend yield of 0.26%. Revenue growth year-over-year stands at 3.91%, while EPS growth is reported at 7.32%. The company’s return on equity is 12.55%, and its current ratio is 1.89.
Conversely, concerns arise from the modest revenue growth of 3.91% year-over-year, which may indicate potential challenges in maintaining momentum. The relatively high P/E ratio of 36.56 could also suggest that the stock is priced for perfection, raising risk levels for investors.
Some investors point to Thermo Fisher's projected 7% organic growth by 2028, driven by increased pharmaceutical spending influenced by AI developments. Additionally, the company anticipates stronger demand, labeling 2026 as an 'Outstanding Year'.
Some investors point to Thermo Fisher's projected 7% organic growth by 2028, driven by increased pharmaceutical spending influenced by AI developments. Additionally, the company anticipates stronger demand, labeling 2026 as an 'Outstanding Year'. Conversely, concerns arise from the modest revenue growth of 3.91% year-over-year, which may indicate potential challenges in maintaining momentum. The relatively high P/E ratio of 36.56 could also suggest that the stock is priced for perfection, raising risk levels for investors.
Thermo Fisher Scientific Inc. has a market capitalization of $245.13B and a current stock price of $648.49, up 1.06% from the previous close of $641.66. The company exhibits a P/E ratio of 36.56 and a dividend yield of 0.26%. Revenue growth year-over-year stands at 3.91%, while EPS growth is reported at 7.32%. The company’s return on equity is 12.55%, and its current ratio is 1.89.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.
Helm Terminal offers free AI-powered stock analysis for TMO at helmterminal.dev/analyze/TMO, updated continuously during US market hours. No signup required.